ART Advanced Research Technologies Inc, Montreal, has bolstered its competitive position in the field of optical molecular imaging following its acquisition of an extensive patent portfolio held by a pioneer in the florescence spectroscopy at the Univ of Maryland. The deal gives the bio-optical imaging company exclusive licensing rights to Dr. Joseph Lakowicz’s extensive optical molecular imaging patent portfolio – technologies that will help in the development of new therapeutic and diagnostic drugs and treatments. Lakowicz, a world renowned biochemist and molecular biologist, also becomes a member of ART’s scientific advisory board. Terms of the deal were not disclosed....